ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 47 filers reported holding ALIGOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $146 | -24.0% | 195 | -1.5% | 0.00% | – |
| Q2 2023 | $192 | +24.7% | 198 | +12.5% | 0.00% | – |
| Q1 2023 | $154 | -6.7% | 176 | +1.7% | 0.00% | – |
| Q4 2022 | $165 | – | 173 | +2.4% | 0.00% | – |
| Q3 2022 | $0 | – | 169 | +35.2% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 125 | -88.1% | 0.00% | – |
| Q1 2022 | $2,000 | -98.0% | 1,053 | -87.7% | 0.00% | – |
| Q4 2021 | $101,000 | +36.5% | 8,563 | +161.9% | 0.00% | – |
| Q1 2021 | $74,000 | -49.0% | 3,269 | -37.7% | 0.00% | – |
| Q4 2020 | $145,000 | – | 5,248 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,320,381 | $47,301,000 | 15.67% |
| Pivotal bioVenture Partners Investment Advisor LLC | 876,548 | $17,873,000 | 7.04% |
| Vivo Capital, LLC | 3,547,030 | $72,306,000 | 3.13% |
| Novo Holdings A/S | 2,614,563 | $53,311,000 | 2.36% |
| ACUTA CAPITAL PARTNERS, LLC | 214,254 | $4,368,000 | 1.75% |
| Boxer Capital, LLC | 1,526,048 | $31,108,000 | 1.10% |
| VR Adviser, LLC | 408,377 | $8,325,000 | 1.01% |
| Cormorant Asset Management, LP | 905,467 | $18,458,000 | 0.63% |
| HHLR ADVISORS, LTD. | 2,165,064 | $44,135,000 | 0.45% |
| Logos Global Management LP | 212,785 | $4,339,000 | 0.36% |